Science behind the Study: Inhibiting IgG in Hemolytic Disease of the Fetus
This editorial describes the science behind a study of the monoclonal antibody nipocalimab to postpone or prevent intrauterine transfusion in pregnancies at high risk...
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras
SARS-CoV-2 infection leads to postacute sequelae in many organ systems. In this study, the risk of postacute sequelae decreased over time but remained substantial...
En Coup de Sabre
A 70-year-old woman presented with a 1-year history of progressive indentation and darkening of the skin of her forehead. On examination, there was a...
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn
In a trial involving 13 pregnancies at high risk for early-onset severe hemolytic disease of the fetus and newborn, nipocalimab increased the percentage with...
Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance
A patient with serious thrombotic episodes was found to have a monoclonal gammopathy of an anti–PF4 antibody. Myeloma therapy reduced the paraprotein level and...
